Tag: engineering
-
Infographic – VR, AR Yet to Reach Critical Mass
While applications of VR and AR technologies can seem compelling, the numbers of people actually using these systems remain relatively small.
-
Primate Genome A.I. Model IDs Human Disease Variants
A genomic systems company created an artificial intelligence algorithm from primate genomic data that identifies possible disease-causing mutations in humans.
-
Lab to Develop New Bio-Based Sustainable Materials
A venture investment fund and university bioengineering center are creating a laboratory to design more sustainable alternative materials to help address the climate crisis.
-
Infographic – U-Turn on A.I. Venture Funds in Q1
Both the total investment dollars and number of venture deals in Q1 2023 are the lowest single quarter totals since 2019.
-
Brain-Computer Device Company Gains $33M in Early Funds
A company creating brain-computer interface devices to help people with disabling communications impairments is raising $33 million in its first venture round.
-
Measles-Rubella Patch Vaccine Shown Effective as Injection
A clinical trial shows a peel-and-stick patch device is as effective as a standard syringe injection in delivering a vaccine that protects against measles and rubella.
-
Biotech, Janssen Partner on Ultrasound for Gene Therapy
A developer of ultrasound bubbles to assist gene therapies is studying use of the technology with Janssen Pharmaceuticals for delivering DNA and RNA treatments.
-
Rare Disease Search Adds Large Language Model A.I.
A company offering a search engine to help diagnose rare diseases is integrating generative models from Open AI into its artificial intelligence algorithms.
-
Infographic – Climate Start-Ups Still Gaining Venture Funds
Despite a sharp downturn in venture dollars from 2021, new climate and weather forecasting companies continue to attract investments at historically high rates.
-
Collaboration to Boost Rare Disease Clinical Trials
An organization seeking new uses for today’s drugs and a contract research company aim to increase the number of clinical trials for rare diseases testing already approved drugs.